ACCD Logo

Accolade, Inc. (ACCD) 

NASDAQ
Market Cap
$280.27M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
504 of 960
Rank in Industry
21 of 43

Largest Insider Buys in Sector

ACCD Stock Price History Chart

ACCD Stock Performance

About Accolade, Inc.

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves …

Insider Activity of Accolade, Inc.

Over the last 12 months, insiders at Accolade, Inc. have bought $0 and sold $2.51M worth of Accolade, Inc. stock.

On average, over the past 5 years, insiders at Accolade, Inc. have bought $178,758 and sold $4.25M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 74 shares for transaction amount of $743 was made by Barnes Stephen H. (Chief Financial Officer) on 2022‑08‑02.

List of Insider Buy and Sell Transactions, Accolade, Inc.

2024-12-17SaleChief Executive Officer
381
0.0005%
$3.43$1,308+2.35%
2024-12-17SaleChief Financial Officer
123
0.0002%
$3.43$422+2.35%
2024-12-17SalePresident
156
0.0002%
$3.43$535+2.35%
2024-12-11SaleChief Executive Officer
667
0.0008%
$3.62$2,416-4.92%
2024-12-11SaleChief Financial Officer
222
0.0003%
$3.62$804-4.92%
2024-12-11SalePresident
214
0.0003%
$3.62$775-4.92%
2024-12-03SaleChief Executive Officer
13,357
0.0165%
$3.60$48,018-1.12%
2024-12-03SaleChief Financial Officer
5,640
0.007%
$3.60$20,276-1.12%
2024-12-03SalePresident
5,582
0.0069%
$3.60$20,067-1.12%
2024-12-03SaleEVP General Counsel
3,581
0.0044%
$3.60$12,874-1.12%
2024-12-03SaleChief Accounting Officer
2,388
0.003%
$3.60$8,585-1.12%
2024-11-19SaleChief Executive Officer
380
0.0005%
$3.35$1,271+5.38%
2024-11-19SaleChief Financial Officer
121
0.0001%
$3.35$405+5.38%
2024-11-19SalePresident
154
0.0002%
$3.35$515+5.38%
2024-11-12SaleChief Executive Officer
668
0.0008%
$3.64$2,430-2.16%
2024-11-12SaleChief Financial Officer
223
0.0003%
$3.64$811-2.16%
2024-11-12SalePresident
214
0.0003%
$3.64$779-2.16%
2024-11-04SaleChief Executive Officer
1,545
0.0019%
$3.15$4,865+14.92%
2024-11-04SaleChief Financial Officer
458
0.0006%
$3.15$1,442+14.92%
2024-11-04SalePresident
475
0.0006%
$3.15$1,496+14.92%

Insider Historical Profitability

16.34%
SINGH RAJEEVChief Executive Officer
815851
1.013%
$3.48168+16.34%
Barnes Stephen H.Chief Financial Officer
220463
0.2737%
$3.48267+16.34%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Brown Advisory$61.27M7.425.85M-1.96%-$1.22M0.08
BlackRock$59.33M7.185.66M+<0.01%+$2,378.96<0.01
ARK Investment Management LLC$58.82M7.125.61M-17.52%-$12.49M0.2
The Vanguard Group$56.63M6.855.4M+1.45%+$807,421.12<0.01
JPMorgan Chase$55.87M6.765.33M-16.83%-$11.31M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.